Determination of albuterol sulfate and its related substances in albuterol sulfate inhalation solution, 0.5% by RP-HPLC

Journal of Pharmaceutical and Biomedical Analysis

Volumn 40, Issue 4, 2006, Pages 864-874

  Erram, Satyajit V ^a,b   Fanska, Cindy B ^a   Asif, Muhammad ^a  

^a Analytical Development Dey LP   (United States)

^b KAISER PERMANENTE   (United States)

Author keywords

Albuterol sulfate; Assay; HPLC; Related substances; RP HPLC; Validation

Indexed keywords

ALDEHYDE DERIVATIVE; BENZENE DERIVATIVE; ETHER DERIVATIVE; METHANOL; PLACEBO; POTASSIUM DIHYDROGEN PHOSPHATE; SALBUTAMOL SULFATE;

ABSORPTION; ACCURACY; ANALYTIC METHOD; ANALYTICAL EQUIPMENT; ARTICLE; CONCENTRATION (PARAMETERS); DRUG DEGRADATION; DRUG DETERMINATION; DRUG FORMULATION; DRUG IMPURITY; DRUG SOLUTION; DRUG STABILITY; FLOW RATE; HYDROPHILICITY; INHALATION; PH; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SENSITIVITY AND SPECIFICITY; SEPARATION TECHNIQUE; STANDARD; VALIDATION PROCESS; VALIDATION STUDY;

ADRENERGIC BETA-AGONISTS; ALBUTEROL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG CONTAMINATION; DRUG STABILITY; REPRODUCIBILITY OF RESULTS; SOLUTIONS;

EID: 32944463449     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2005.08.021     Document Type: Article

References (11)

1. United States Pharmacopoeia and National Formulary, US 28-NF 23, 2005, Chapter 621, pp. 57-58, 2380-2392.
2. British Pharmacopoeia, vol. I, 2001, pp. 1445-1447.
3. N. Beaulieu, T.D. Cyr, and E.G. Lovering J. Pharm. Biomed. Anal. 8 1990 583 589
4. J.L. Bernal, M.J. del Nozal, H. Velasco, and L. Torbio J. Liq. Chrom. Rel. Technol. 19 1996 1579 1589
5. A. Halabi, C. Ferrayoli, M. Palacio, V. Dabbene, and S. Palacios J. Pharm. Biomed. Anal. 34 2004 45 51
6. A. Bartolincic, V. Druskovic, A. Sporec, and V. Vinkovic J. Pharm. Biomed. Anal. 36 2005 1003 1010
7. N. Dimova Chromatographia 57 2003 487 490
8. M.T. Ackermans, J.L. Beckers, F.M. Everaerts, and I.G.J.A. Seelen J. Chromatogr. 590 1992 341 353
9. I. Dol, and M. Knochen Talanta 64 2004 1233 1236
10. N.T. Abdel-Ghani, R.M. El-Nashar, and M.S. Rizk Anal. Lett. 35 2002 39 52
11. Draft Guidance for Industry: Analytical Procedures and Methods Validation, U.S. Department of Health and Human Services, Food and Drug Administration, August 2000.